Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin‐4 Antibody Diseases

Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults

(2019) Alvaro Cobo-Calvo et al.   JOURNAL OF NEUROLOGY

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

(2019) Alvaro Cobo-Calvo et al.   Journal of Neuroinflammation

Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein

(2018) Melania Spadaro et al.   ANNALS OF NEUROLOGY

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study

(2018) Philippe Cabre et al.   JOURNAL OF NEUROLOGY

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

(2018) Alvaro Cobo-Calvo et al.   NEUROLOGY

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

(2018) Yael Hacohen et al.   JAMA Neurology

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

(2018) Ivan Jelcic et al.   CELL

The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy

(2018) Malika Hale et al.   CURRENT OPINION IN IMMUNOLOGY

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination

(2017) Patrick Peschl et al.   Journal of Neuroinflammation

What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients

(2017) Shahd H. M. Hamid et al.   JOURNAL OF NEUROLOGY

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

(2017) Sudarshini Ramanathan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Monitoring CD27 + memory B-cells in neuromyelitis optica spectrum disorders patients treated with rituximab: Results from a bicentric study

(2017) M. Cohen et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Plasma cell survival in the absence of B cell memory

(2017) Erika Hammarlund et al.   Nature Communications

Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen

(2016) Silke Kinzel et al.   ACTA NEUROPATHOLOGICA

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome

(2016) Sven Jarius et al.   Journal of Neuroinflammation

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study

(2016) Pietro Annovazzi et al.   JOURNAL OF NEUROLOGY

Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease

(2016) Anne-Christine Flach et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders

(2016) Valentina Damato et al.   JAMA Neurology

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS

(2015) Bleranda Zeka et al.   ACTA NEUROPATHOLOGICA

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability

(2015) Hélène Zéphir et al.   JOURNAL OF NEUROLOGY

Efficacy of rituximab in refractory neuromyelitis optica

(2015) N Collongues et al.   Multiple Sclerosis Journal

Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

(2015) M Radaelli et al.   Multiple Sclerosis Journal

Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications

(2015) Álvaro Cobo-Calvo et al.   Multiple Sclerosis Journal

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica

(2015) Su-Hyun Kim et al.   JAMA Neurology

Efficacy of rituximab in refractory neuromyelitis optica

(2015) N Collongues et al.   Multiple Sclerosis Journal

Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients

(2015) M Radaelli et al.   Multiple Sclerosis Journal

Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications

(2015) Álvaro Cobo-Calvo et al.   Multiple Sclerosis Journal

Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers

(2014) E. F. Wallin et al.   BLOOD

A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function

(2013) E. G. Kamburova et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica

(2013) Claudia F. Lucchinetti et al.   BRAIN PATHOLOGY

A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder

(2013) Su-Hyun Kim et al.   JAMA Neurology

B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells

(2012) Matthieu Mahévas et al.   JOURNAL OF CLINICAL INVESTIGATION

Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years

(2011) Su-Hyun Kim   ARCHIVES OF NEUROLOGY

Immunologic effects of rituximab on the human spleen in immune thrombocytopenia

(2011) S. Audia et al.   BLOOD

Impact of rituximab on relapse rate and disability in neuromyelitis optica

(2011) Gurdesh S Bedi et al.   Multiple Sclerosis Journal

Long-lived autoreactive plasma cells drive persistent autoimmune inflammation

(2011) Falk Hiepe et al.   Nature Reviews Rheumatology

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

(2011) H. L. Pellkofer et al.   NEUROLOGY

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury

(2010) Romain Marignier et al.   BRAIN

B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy

(2009) Olivier Thaunat et al.   TRANSPLANTATION

Treatment of Neuromyelitis Optica With Rituximab

(2008)   ARCHIVES OF NEUROLOGY

The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells

(2008) M. Mamani-Matsuda et al.   BLOOD

Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica

(2008) Sven Jarius et al.   Nature clinical practice. Neurology